Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11018486 | Journal of Microbiology, Immunology and Infection | 2018 | 8 Pages |
Abstract
When treating MAC diseases, species identification plays an important role in choosing treatment regimens. Combination of isepamicin and clofazimine may be a promising regimen in M. intracellulare-associated disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Chen-Cheng Huang, Ming-Feng Wu, Hui-Chen Chen, Wei-Chang Huang,